Alzinova AB (publ) ("Alzinova" or "the Company"), announces that a second external safety review has been carried out of the Company's clinical phase 1b...
Tetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development announced they signed an agreement with Cellvera Global Holdings LLC ("Cellvera"), for the...
Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, announced that the...
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis delta virus (HDV) and other serious diseases, provided...
InnoCare Pharma, a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced that BTK inhibitor orelabrutinib has been granted priority review...
